One of the things I would like to say is that people often say if we start testing and treating MS patients right now, it will take away from doing clinical trials. This is totally false. First of all, trials are usually very small, 100 to 200 people, so what happens to the rest of the 74,000 MS patients? The second thing is trials don't include people usually in the progressive forms of MS very often. Sometimes they do, but usually they don't.
Third, a lot of people with MS who have had MS for more than a certain number of years are excluded, as are people with other chronic conditions. I have Crohn's disease as well, and I would never be even eligible for a clinical trial. So people very often will use that myth, that if we don't do a clinical trial, if we start testing people, we won't have people for clinical trials. That's not true.
That's the only thing I wanted to add.